BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12439363)

  • 21. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Faddy SC
    Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
    [No Abstract]   [Full Text] [Related]  

  • 22. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
    Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-induced nephropathy.
    McCullough PA; Soman SS
    Crit Care Clin; 2005 Apr; 21(2):261-80. PubMed ID: 15781162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of acute renal failure.
    Needham E
    Am Fam Physician; 2005 Nov; 72(9):1739-46. PubMed ID: 16300036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
    La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S
    In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contrast medium induced nephropathy: pathogenesis, clinical aspects, prevention].
    Haller C; Kübler W
    Dtsch Med Wochenschr; 1999 Mar; 124(11):332-6. PubMed ID: 10209535
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiocontrast-induced nephropathy.
    Solomon R
    Semin Nephrol; 1998 Sep; 18(5):551-7. PubMed ID: 9754608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast nephropathy.
    Finger MA; Ramsay A
    Am Fam Physician; 1987 Jun; 35(6):171-5. PubMed ID: 3504103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N-acetylcysteine on radiocontrast nephropathy in rats.
    Yenicerioglu Y; Yilmaz O; Sarioglu S; Ormen M; Akan P; Celik A; Camsari T
    Scand J Urol Nephrol; 2006; 40(1):63-9. PubMed ID: 16452059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
    Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiocontrast-induced nephropathy: current status and future prospects.
    Margulies K; Schirger J; Burnett J
    Int Angiol; 1992; 11(1):20-5. PubMed ID: 1387889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department.
    Sinert R; Doty CI
    Ann Emerg Med; 2007 Sep; 50(3):335-45, 345.e1-2. PubMed ID: 17512638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contrast media-associated nephropathy--pathogenesis and prevention].
    Erley CM; Duda SH
    Aktuelle Radiol; 1997 Jul; 7(4):189-92. PubMed ID: 9340015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of contrast media: an update.
    ten Dam MA; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):416-22. PubMed ID: 19011267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Consequences of intravascular contrast media on kidney function-- risk and prevention].
    Erley CM; Bader BD
    Rofo; 2000 Oct; 172(10):791-7. PubMed ID: 11111289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-induced nephropathy: a review.
    Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
    Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of contrast-induced nephropathy: a critical review.
    Van Praet JT; De Vriese AS
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):336-47. PubMed ID: 17565276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.